FREE COMMUNICATION 25


10:45 - 12:15     CAPITAL SUITE 10/11

Free Communication Session 25 + Mini Lecture

Diabetic nephropathy - new therapies

Chairs: Myftar Barbullushi, Tirana, Albania
             Luigi Gnudi, London, UK

Mini lecture
Diabetic nephropathy - from the registry to clinical management
Ivan Rychlik, Prague, Czech Republic

FREE COMMUNICATIONS

SuO020
SODIUM GLUCOSE COTRANSPORTERS AS NEW TARGETS OF RAAS INHIBITORS IN DIABETIC NEPHROPATHY
Dora B. Balogh1, Judit Hodrea1, Lilla Lenart1, Sandor Koszegi1, Renata Gellai1, Adam Vannay2, Laszlo J. Wagner3, Attila J. Szabo2, Andrea Fekete1, 1MTA-SE „Lendület” Diabetes Research Group, 1st Dept Pediatrics, Semmelweis Univ, Budapest, HUNGARY, 2MTA-SE Pediatrics and Nephrology Research Group, 1st Dept Pediatrics, Semmelweis Univ, Budapest, HUNGARY, 3Dept Transplantation and Surgery, Semmelweis Univ, Budapest, HUNGARY.

SuO021
INHIBITION OF COLLAGEN CROSS-LINKING BY LYSYL OXIDASE PREVENTS HYPERTROPHY AND PROTECTS FROM DIABETIC NEPHROPATHY.
Tetsuhiro Tanaka, Shinji Tanaka, Hisako Saito, Junna Yamaguchi, Yoshiki Higashijima, Masaomi Nangaku, Univ Tokyo, Div Nephrology and Endocrinology, Tokyo, JAPAN.

SuO022
MICRORNA-21 AS THERAPEUTIC TARGET IN DIABETIC NEPHROPATHY
Malte Kölling1, Tamás Kaucsár2, Celina Schauerte1, Joon-Keun Park3, Péter Hamar2, Hermann Haller3, Thomas Thum1, Johan M. Lorenzen1,3, 1Hannover Medical School, Inst Molecular and Translational Therapeutic Strategies, Hannover, GERMANY, 2Semmelweis Univ, Inst Pathophysiology, Budapest, HUNGARY, 3Hannover Medical School, Dept Medicine, Div Nephrology and Hypertension, Hannover, GERMANY.

SuO023
EFFECTS OF VASOPRESSIN V2 RECEPTOR ANTAGONISM ON THE PROGRESSION OF DIABETIC NEPHROPATHY IN MOUSE MODEL OF TYPE 2 DIABETES
Ray ElBoustany1, Christopher Taveau1, Catherine Chollet1, Gilberto Velho1, Lise Bankir1, Ronan Roussel1,2, Nadine Bouby1, 1INSERM UMRS1138, Centre Recherches des Cordeliers, Paris, FRANCE, 2Bichat Hosp, Diabetology Endocrinology and Nutrition, Paris, FRANCE.

 

back to the timetable